All Stories

  1. Radiotherapy for anal squamous cell carcinoma: must the upper pelvic nodes and the inguinal nodes be treated?

    Article • ANZ Journal of Surgery, March 2018, Wiley

    Mr Chris Brown

  2. Can pelvic floor trauma be predicted antenatally?

    Article • Acta Obstetricia Et Gynecologica Scandinavica, March 2018, Wiley

    Mr Chris Brown

  3. Screening the second-trimester fetal heart in women with an increased body mass index using three-dimensional volume sweep

    Article • Australasian Journal of Ultrasound in Medicine, December 2017, Wiley

    Mr Chris Brown

  4. Changes in maternal abdominal subcutaneous fat layers using ultrasound: A longitudinal study

    Article • Obesity Research & Clinical Practice, November 2017, Elsevier

    Mr Chris Brown

  5. Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study

    Article • PLoS ONE, October 2017, PLOS

    Mr Chris Brown

  6. The Nepean Belief Scale: preliminary reliability and validity in obsessive–compulsive disorder

    Article • International Journal of Psychiatry in Clinical Practice, September 2017, Taylor & Francis

    Mr Chris Brown

  7. End-of-life prescribing of aspirin in patients with breast or colorectal cancer

    Article • BMJ Supportive & Palliative Care, August 2017, BMJ

    Mr Chris Brown

  8. Comorbidity, age of onset and suicidality in obsessive–compulsive disorder (OCD): An international collaboration

    Article • Comprehensive Psychiatry, July 2017, Elsevier

    Mr Chris Brown

  9. The Relationship between Dyslipidemia and Acute Axonal Function in Type 2 Diabetes Mellitus In Vivo

    Article • PLoS ONE, April 2016, PLOS

    Mr Chris Brown

  10. How are cancer patients with medical cards different? Does this affect research?

    Article • Irish Journal of Medical Science (1971 -), October 2015, Springer Science + Business Media

    Mr Chris Brown

  11. Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma

    Article • Neuro-Oncology, June 2015, Oxford University Press (OUP)

    Mr Chris Brown

  12. Treatment Strategies and Survival of Older Breast Cancer Patients – An International Comparison between the Netherlands and Ireland

    Article • PLoS ONE, February 2015, PLOS

    Mr Chris Brown

  13. Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: Results from a subset analysis of the CALYPSO phase III trial

    Article • European Journal of Cancer, February 2015, Elsevier

    Mr Chris Brown

  14. Patterns of care in adult medulloblastoma: results of an international online survey

    Article • Journal of Neuro-Oncology, July 2014, Springer Science + Business Media

    Mr Chris Brown

  15. Rates of obstetric intervention and associated perinatal mortality and morbidity among low-risk women giving birth in private and public hospitals in NSW (2000–2008): a linked data population-based cohort study

    Article • BMJ Open, May 2014, BMJ

    Mr Chris Brown

  16. A phase II clinical trial of the Vascular Disrupting Agent BNC105P as second line chemotherapy for advanced Malignant Pleural Mesothelioma

    Article • Lung Cancer, September 2013, Elsevier

    Mr Chris Brown

  17. Markers of systemic inflammation predict survival in patients with advanced renal cell cancer

    Article • British Journal of Cancer, June 2013, Springer Science + Business Media

    Mr Chris Brown

  18. Impact of EGFR Inhibitor in Non-Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis

    Article • JNCI Journal of the National Cancer Institute, April 2013, Oxford University Press (OUP)

    Mr Chris Brown

  19. Risk of recurrence, subsequent mode of birth and morbidity for women who experienced severe perineal trauma in a first birth in New South Wales between 2000 –2008: a population based data linkage study

    Article • BMC Pregnancy and Childbirth, April 2013, Springer Science + Business Media

    Mr Chris Brown

  20. Trends and risk factors for severe perineal trauma during childbirth in New South Wales between 2000 and 2008: a population-based data study

    Article • BMJ Open, January 2013, BMJ

    Mr Chris Brown

  21. Intravesical chemotherapy plus bacille Calmette-Guérin in non-muscle invasive bladder cancer: a systematic review with meta-analysis

    Article • BJU International, December 2012, Wiley

    Mr Chris Brown

  22. Long-Term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-Binding Protein 4 in Subjects with Type 2 Diabetes

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2012, Endocrine Society

    Mr Chris Brown

  23. A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer

    Article • Annals of Oncology, October 2012, Oxford University Press (OUP)

    Mr Chris Brown

  24. Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients

    Article • British Journal of Cancer, July 2012, Springer Science + Business Media

    Mr Chris Brown

  25. Corrigendum to “Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis” [Eur J Cancer 47 (12) (2011) 1826–1836]

    Article • European Journal of Cancer, February 2012, Elsevier

    Mr Chris Brown

  26. Health-related quality of life in recurrent platinum-sensitive ovarian cancer--results from the CALYPSO trial

    Article • Annals of Oncology, January 2012, Oxford University Press (OUP)

    Mr Chris Brown

  27. CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial

    Article • British Journal of Cancer, January 2012, Springer Science + Business Media

    Mr Chris Brown

  28. Rates of obstetric intervention among low-risk women giving birth in private and public hospitals in NSW: a population-based descriptive study

    Article • BMJ Open, January 2012, BMJ

    Mr Chris Brown

  29. The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine–oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer

    Article • British Journal of Cancer, December 2011, Springer Science + Business Media

    Mr Chris Brown

  30. Phase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy

    Article • Journal of Clinical Neuroscience, November 2011, Elsevier

    Mr Chris Brown

  31. Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial

    Article • Annals of Oncology, October 2011, Oxford University Press (OUP)

    Mr Chris Brown

  32. Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer

    Article • British Journal of Cancer, September 2011, Springer Science + Business Media

    Mr Chris Brown

  33. Early Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian Cancer

    Article • JNCI Journal of the National Cancer Institute, August 2011, Oxford University Press (OUP)

    Mr Chris Brown

  34. Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis

    Article • European Journal of Cancer, August 2011, Elsevier

    Mr Chris Brown

  35. Carboplatin–paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer

    Article • British Journal of Cancer, July 2011, Springer Science + Business Media

    Mr Chris Brown

  36. Lung cancer clinicians’ preferences for adjuvant chemotherapy in non-small-cell lung cancer: What makes it worthwhile?

    Article • Lung Cancer, May 2011, Elsevier

    Mr Chris Brown

  37. Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study

    Article • Annals of Oncology, March 2011, Oxford University Press (OUP)

    Mr Chris Brown

  38. Population Case-Control Study of Cerebral Palsy: Neonatal Predictors for Low-Risk Term Singletons

    Article • PEDIATRICS, February 2011, American Academy of Pediatrics (AAP)

    Mr Chris Brown

  39. Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse

    Article • Journal of Clinical Oncology, May 2010, American Society of Clinical Oncology (ASCO)

    Mr Chris Brown

  40. Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas

    Article • Cancer Chemotherapy and Pharmacology, May 2010, Springer Science + Business Media

    Mr Chris Brown